Description: Bioxyne Limited is an Australia-based bio-technology company engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company has an agreement to manufacture, market, supply and distribute its probiotic strain for over the counter dietary supplement products. Its segments include Probiotics and Other. It focuses on immune health and immunotherapeutic products. The Company's focus is on its probiotic business and product Lactobacillus fermentum PCC. The Company holds an interest in Mariposa Health Limited, a pharmaceutical development company with a focus on Congestive and Obstructive Pulmonary Disease (COPD).
Home Page: www.bioxyne.com
BXN Technical Analysis
50 Clarence Street
Sydney,
NSW
2000
Australia
Phone:
61 2 9078 8180
Officers
| Name | Title |
|---|---|
| Mr. Nam Hoat Chua B.A., BA | MD, CEO & Director |
| Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICD | CFO, Company Sec. & Exec. Director |
| Ms. Rachel Qian | Financial Controller & Assistant Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.1008 |
| Price-to-Sales TTM: | 6.965 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |